Citius Pharmaceuticals Inc. (CTXR) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan
Citius Pharmaceuticals is diversifying its operations by developing treatments for oncology and critical care. This chart illustrates the current share value with an EV/EBITDA ratio of 0.00. This price action reflects the potential for premium pricing following the approval of its lymphoma therapy, while ultimate success depends on the commercialization of Mino-Lok and the completion of final trials for its intensive care drugs.
CTXR (citiuspharma.com): rincian analitis lan laporan miturut indikator
- rega saham lan target rega konsensus:
- indikator kapitalisasi pasar:
- indikator nilai buku ekuitas:
- data utang lan likuiditas:
Utang marang Ekuitas Citius Pharmaceuticals|CTXR - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Citius Pharmaceuticals, Inc.|CTXR - Utang perusahaan|Rasio utang marang kapitalisasi buku Citius Pharmaceuticals, Inc.|CTXR - Utang jangka dawa|Utang jangka cendhak perusahaan Citius Pharmaceuticals|Indikator likuiditas cepet citiuspharma.com
- data bathi bisnis lan rasio investasi:
CTXR - Penghasilan resik perusahaan|Bathi mangsa ngarep Citius Pharmaceuticals|CTXR - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi Citius Pharmaceuticals, Inc.|CTXR - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Citius Pharmaceuticals, Inc.|CTXR - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Citius Pharmaceuticals|CTXR - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan citiuspharma.com|CTXR - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Citius Pharmaceuticals
Ringkesan analitik perusahaan:CTXR (Citius Pharma)
By utilizing a virtual operating model that outsources all testing to third-party contractors, Citius Pharmaceuticals (CTXR) minimizes capital expenditures, which directly impacts the calculation of enterprise value relative to its operating profit. Analyzing the EV/EBITDA valuation multiple for capital-intensive businesses, an investor determines the payback period for assets excluding taxes and interest, where the stability of the curve may signal either reliability or stagnation.
Analisis pesaing
Incyte Corp. - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai bisnis marang bathi operasional sadurunge panyusutan HCM|NUVB - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan dayonebio.com|Monopar Therapeutics Inc. (MNPR) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi operasional sadurunge panyusutan INBX|IMAB (I-Mab Biopharma Co., Ltd.) - Pangali EV/EBITDA|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Fennec (FENC)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Heron Therapeutics (HRTX)|NVCT - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Coherus BioSciences Inc. CHRS|Corbus Pharmaceuticals Holdings, Inc. - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|CRDF - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan BeyondSpring Inc|BCAB: Pangali EV/EBITDA|Pangali nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan lixte.com LIXT|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CLRB|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan BioLineRx Ltd BLRX|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CANF (Can-Fite BioPharma, Ltd.)|APRE (aprea.com) - Nilai bisnis marang bathi operasional sadurunge panyusutan|Kazia Therapeutics Limited - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan SLXN (Silexion Therapeutics Corp.)|NuCana Corp - Pangali EV/EBITDA|Nilai bisnis marang bathi operasional sadurunge panyusutan CMRX (Chimerix Inc.)|CYCC: Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan G1 Therapeutics (GTHX)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Kronos Bio, Inc.|KTRA: Nilai bisnis marang bathi operasional sadurunge panyusutan|Pangali EV/EBITDA ONCT|Pangali EV/EBITDA Portage Biotech Inc (PRTG)
